Introduction
============

C2 is the most commonly injured vertebra in the cervical spine in those aged \>65 years \[[@b1-asj-2018-0300]\]. While the majority of C2 fractures in elderly patients are caused by a fall from standing height, the implication of this injury for the individual is far from simple. Associated mortality and morbidity rates are significant, with 1-year mortality rates as high as 37.5% having been reported \[[@b2-asj-2018-0300]\], comparative to those of neck of femur fractures, indicating a potential end-of-life event for vulnerable elderly patients. With an aging population globally, it is expected that the incidence of these fractures will continue to rise.

Previous studies focusing on odontoid fractures in the elderly have attempted to ascertain risk factors associated with mortality and poor outcome. In a recent retrospective review of 83 elderly patients, Bajada et al. \[[@b3-asj-2018-0300]\] established predictive risk factors, including low serum hemoglobin, neurological deficit on presentation, admission from an institution, and type 3 odontoid fractures for 30-day and 1-year mortality. Tashjian et al. \[[@b4-asj-2018-0300]\] also found that immobilization with a halo-vest significantly increased mortality rate. The identification of such associations is clinically important for risk stratification, treatment decision making, and providing meaningful outcome counseling for patients and their family.

Similar observations have been the focus of investigations on neck of femur fractures in the elderly, whereby comorbidities have been shown to correlate with increased mortality rate and poorer outcomes. In particular, the Charlson Comorbidity Index (CCI) has remained a popular predictive scoring tool to represent the disease burden on a patient in both clinical and research settings \[[@b5-asj-2018-0300],[@b6-asj-2018-0300]\]. However, whether this is a significant predictor of mortality rates in C2 fractures of the elderly remains to be elucidated. In recent years, frailty has also become an increasingly recognized concept to define elderly vulnerability and dependence as a separate entity to comorbidity and disability \[[@b7-asj-2018-0300],[@b8-asj-2018-0300]\]. The modified Frailty Index (mFI), developed from the Canadian Study of Health and Aging Frailty Index, has been shown to be a reliable tool for preoperative risk stratification in specialties including neurosurgery, cardiovascular surgery \[[@b9-asj-2018-0300]-[@b11-asj-2018-0300]\], and spinal surgery \[[@b12-asj-2018-0300],[@b13-asj-2018-0300]\].

The present study aimed to establish the 30-day and 1-year mortality rates for elderly patients with traumatic C2 fractures treated at Waikato Hospital, New Zealand and to identify risk factors for mortality at these time points. CCI and mFI were included to determine their potential association with mortality rates.

Materials and Methods
=====================

A retrospective review was performed of all patients aged ≥65 years with acute C2 fractures identified on computed tomography (CT) scans between 2010 and 2016 from the radiology trauma database. This retrospective outcomes analysis was approved by the Waikato Hospital Clinical Audit Support Unit (ref: 3783) and the requirement for informed consent waived. The analysis was performed in compliance with the Health Information Privacy Code 1994. Pathological fractures secondary to tumor, infection, or metastatic disease were excluded.

1. Demographics
---------------

Hospital electronic and paper records were reviewed to collect demographic information, including age, gender, and ethnicity, in addition to admission details. Previous medical history and mental (presence of dementia or cognitive impairment) and functional status prior to injury were recorded to enable calculation of the CCI and mFI.

2. Charlson Comorbidity Index and modified Frailty Index
--------------------------------------------------------

The CCI places different weights on age brackets, selected disease categories and the severities of diseases to predict mortality rate, originally presented as an estimated 10-year survival rate. For example, a CCI of ≥5 estimates a 10-year survival rate of 21%, whereas a score of 2 predicts a 10-year survival rate of 90% \[[@b14-asj-2018-0300]\]. The mFI is an 11-item score, which divides the number of conditions or functional/mental deficits present by 11, resulting in an index value between 0 and 1 for the patient to be classified as 'robust,' 'pre-frail,' or 'frail.' The closer the value is to 1, the frailer the individual \[[@b15-asj-2018-0300]\]. The exact variables used to calculate both these scores are presented in [Table 1](#t1-asj-2018-0300){ref-type="table"}.

3. Biochemical markers
----------------------

Serologic results on admission, including lymphocyte count, creatinine, albumin, and hemoglobin levels, were collated. Creatinine, albumin, and lymphocyte counts have all been linked to the presence of malnutrition and are thus considered to be a potential predictor of poor outcome \[[@b16-asj-2018-0300]-[@b18-asj-2018-0300]\].

4. Other variables
------------------

Details on the mechanism of injury and presence of neurological symptoms on admission were also recorded. The types of C2 fractures were classified into Anderson and D'Alonzo types I, II, & III for odontoid fractures, and others for Hangman's or atypical variant fractures. Severity was also considered, with fracture displacement determined by angulation and translation on CT where applicable, and associated fractures or injuries (e.g., femur and pelvic fractures) were recorded. Finally, treatment modality was recorded for descriptive analysis. All CT scans were reviewed by the lead and senior authors to determine the fracture type and displacement prior to the collection of other data. The decision regarding treatment strategy, whether nonsurgical or surgical, was made by the responsible spine surgeon at the time of admission.

All available data for up to 1 year post-injury were reviewed. The outcome measures comprised 90-day readmission rate, length of stay (LOS), and mortality rates at both 30 days and 1 year.

5. Statistical analysis
-----------------------

Pearson bivariate analysis was used to gage the associations between CCI, mFI, and serologic tests with 90-day readmission rates, LOS, and 30-day and 1-year mortality rates. Forward stepwise logistic regression modeling was then used to determine significant predictors of mortality within 30 days and 1 year of admission among the covariates of age, gender, mFI, CCI, hemoglobin, lymphocyte count, creatinine, and albumin levels. All *p*\<0.05 were considered to indicate a statistically significant difference.

Results
=======

1. Descriptive analysis
-----------------------

Following the exclusion of one pathological fracture, a total of 70 patients with traumatic C2 fractures were included in the data collection. The mean age at presentation was 80.6±8.5 years, with the oldest patient aged 97 years; 60% of patients were female (n=42), and the majority were of European descent (88%, n=62).

The most common mechanism of injury was falling from standing height (74.3%, n=52), and 8% (n=11) presented with abnormal neurological symptoms or signs. The majority of patients were treated nonsurgically, with either a hard or soft collar, with 11.4% undergoing some form of surgical stabilization or fixation (n=8).

The mean CCI among all patients was 5, and the mean mFI was 0.21 (pre-frail). The mean inpatient LOS was 10.4±12.5 days, and 20 patients (28.5%) were re-admitted to hospital within 3 months. The mortality rates were 14.3% (n=10) at 30 days and 35.7% (n=25) at 1 year ([Table 2](#t2-asj-2018-0300){ref-type="table"}).

2. Bivariate analysis
---------------------

Pearson's correlation results are shown in [Table 3](#t3-asj-2018-0300){ref-type="table"}. Increased CCI correlated linearly with both 30-day (*R*=0.367, *p*=0.002) and 1-year (*R*=0.690, *p*\<0.001) mortality rates. Increased mFI also correlated with both 30-day (*R*=0.313, *p*=0.008) and 1-year (*R*=0.583, *p*=0.005) mortality rates, and with readmission rate within 90 days (*R*=0.331, *p*=0.005). There was no association between a classification of 'robust' (mFI=0) or 'pre-frail' (mFI=0.09--0.18) with increased mortality rate, whereas 'frail' (mFI ≥0.27) was significantly correlated with increased 1-year mortality (*R*=0.538, *p*=001). Albumin and hemoglobin levels were inversely correlated with both the 30-day (*R*=−0.286, *p*=0.016; *R*=−0.373, *p*=0.001) and 1-year (*R*=−0.350, *p*=0.003; *R*=−0.319, *p*=0.007) mortality rates.

3. Multivariate analysis
------------------------

Forward stepwise logistic regression modeling adjusting for age, gender, CCI, mFI, hemoglobin level, lymphocyte count, albumin, and creatinine determined that increased CCI (odds ratio \[OR\], 1.614; 95% confidence interval \[CI\], 1.145--2.276; *p*=0.006), reduced hemoglobin level (OR, 0.919; 95% CI, 0.866--0.975; *p*=0.005), and reduced creatinine level (OR, 0.989; 95% CI, 0.976--1.002; *p*=0.095) were the highest predictors of 30-day mortality rates, reaching inclusion into the final model (*R*^2^=0.431). Increased CCI (OR, 2.875; 95% CI, 1.579--5.235; *p*=0.001), increased age (OR, 1.154; 95% CI, 1.003--1.329; *p*=0.045), reduced albumin level (OR, 0.762; 95% CI, 0.621--0.936; *p*=0.01), and female gender (OR, 11.188; 95% CI, 1.307--95.795; *p*=0.028) were predictors of 1-year mortality rate, reaching inclusion to the final model (*R*^2^=0.762) ([Table 4](#t4-asj-2018-0300){ref-type="table"}). By contrast, mechanism of injury, fracture type, displacement, associated injuries, presence of neurological deficits, and treatment modality were not correlated with mortality rates at either 30 days or 1 year in the analysis.

Discussion
==========

The present study aimed to determine the 30-day and 1-year mortality rates in elderly patients with traumatic C2 fractures and identify risk factors for mortality. A significant 1-year mortality rate of 35.7% was noted, similar to that of previous reports reported in elderly patients with hip fractures \[[@b2-asj-2018-0300],[@b19-asj-2018-0300]-[@b22-asj-2018-0300]\].

Although increased comorbidity status and frailty were associated with mortality rates at both 30 days (low positive correlation) and 1 year (moderately positive) in the bivariate analysis, multivariate analysis determined that, of the two measures, only CCI was a significant predictor of mortality rate at both time points. The present study is the first, to the best of our knowledge, to show that CCI independently predicts mortality rate in elderly patients with C2 fractures. Several studies have reported that comorbidity is a reliable predictor of mortality rates and postoperative outcomes in a number of pathologies, including elderly patients with femur fractures, both proximal and distal, spinal disorders, and undergoing spinal surgery \[[@b5-asj-2018-0300],[@b6-asj-2018-0300],[@b23-asj-2018-0300]-[@b25-asj-2018-0300]\]. Therefore, the present study reaffirms that pre-injury disease burden and the comorbidity status adversely affect survival rate in the setting of elderly C2 fractures. Of readmissions, almost none were associated with fracture or injury itself, but rather medical conditions including urinary tract infections, lower respiratory infections, or gastrointestinal complaints (e.g., constipation).

The present study used the mFI to examine frailty as a risk factor, focusing on the pre-injury functional dependance and physical vulnerability of the patient to medical insults or injuries. It was hypothesized that mFI is a significant predictor as, similar to the CCI, it has been linked to morbidity and mortality rates in similar settings \[[@b9-asj-2018-0300]-[@b13-asj-2018-0300]\], and was shown to correlate with mortality rate in the initial bivariate analysis performed. However, the results of the multivariate regression model failed to show mFI as a risk factor.

Bajada et al. \[[@b3-asj-2018-0300]\] reported a low hemoglobin level as a predictor of mortality rate, and the results of the present study confirm this association. Anemia likely serves a role as an indicator of a chronic disease state and consequently a reduced physiological reserve. In addition, the present study found that low serum albumin was another significant risk factor associated with 1-year mortality rate. Previously, Chung et al. \[[@b26-asj-2018-0300]\] showed that increasing severity of malnutrition, as defined by the level of albumin deficiency, predicts progressively poorer 30-day outcomes in patients undergoing hip fracture surgery. Either reduced hepatic protein synthesis or a malnourished state can result in lowered serum albumin and should prompt appropriate multidisciplinary input.

Treatment of C2 fractures at our center over the study period was predominantly conservative, with only 11.4% of patients undergoing surgical management, similar to studies from centers in other geographic regions \[[@b22-asj-2018-0300],[@b27-asj-2018-0300]\]. Although Pearson et al. \[[@b22-asj-2018-0300]\] reported reduced 30-day and 1-year mortality rates with surgical stabilization in their Medicare cohort, the mortality rates in the cohort examined in the present study do not appear to correlate with treatment modality. This may represent the range of physiologic states encountered in patients aged \>65 years and their consequent fitness for an invasive procedure, a key consideration in determining optimal fracture treatment.

There were limitations to the present study. It was retrospective in nature, and any retrospective analysis is influenced by the accuracy of prior documentation. The present study included all C2 fracture patterns and all mechanisms of injury and treatment modalities. With the retrospective study reviewing cases, which occurred over a period of 7 years, and with multiple surgeons being involved, there is a potential for variation in treatment, even for similar fracture patterns. However, it is difficult to control for surgical indication and choice of treatment due to the above findings, and there may be additional confounding factors; however, inherent individual differences exist even in similar injury patterns (e.g., level of comorbidities and fitness for surgery), which cannot be easily controlled. Although this creates a level of heterogeneity in the cohort, it also means the results are more broadly applicable. Indeed the fracture patterns and mechanism in this cohort did not correlate with any of the outcome measures in the analyzes. The trend of treatment at our center was toward nonsurgical treatment for most cases of C2 fractures, and hard or rigid orthoses were avoided in those at risk of pressure sores and aspiration pneumonia.

Conclusions
===========

The results of the present study reaffirm the significant mortality associated with C2 fractures in the geriatric population, with a rate approaching 40% at 1 year. It also established that comorbidity status, as indicated by the CCI, low serum hemoglobin, low serum albumin, increased age, and female gender were associated with 1-year mortality rate.
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###### 

Individual variables and weights of clinical conditions or situations used to calculate the Charlson Comorbidity Index and modified Frailty Index, respectively

  Condition (or history of)                                                                                                                                                                                                                                                                                                                                                                                                                                                      Weight
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------
  Charlson Comorbidity Index                                                                                                                                                                                                                                                                                                                                                                                                                                                     
   Age 50--59 yr; coronary artery disease; congestive heart failure; chronic pulmonary disease; peptic ulcer disease; peripheral vascular disease; mild liver disease; cerebrovascular disease; connective tissue disease; diabetes mellitus; dementia                                                                                                                                                                                                                           1
   Age 60--69 yr; hemiplegia; moderate to severe renal disease; diabetes with end-organ damage; localised solid tumour; leukaemia; lymphoma                                                                                                                                                                                                                                                                                                                                      2
   Age 70--79 yr; moderate to severe liver disease                                                                                                                                                                                                                                                                                                                                                                                                                               3
   Age ≥80 yr                                                                                                                                                                                                                                                                                                                                                                                                                                                                    4
   Metastatic solid tumour; acquired immune deficiency syndrome (not only human immunodeficiency virus positive)                                                                                                                                                                                                                                                                                                                                                                 6
   Score                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sum
  Modified Frailty Index                                                                                                                                                                                                                                                                                                                                                                                                                                                         
   Diabetes mellitus; congestive heart failure; hypertension requiring medication; transient ischaemic attack; cerebrovascular accidents/stroke with neurological deficit; impaired functional status (require home help, or in residential care); myocardial infarction within 6 months; peripheral vascular disease or rest pain; acute or chronic lung diseases; impaired sensorium; cardiac history of angina, prior cardiac surgery, or percutaneous cardiac intervention   1
   Score                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sum÷11

###### 

Descriptive univariate analysis of traumatic C2 fractures in patients aged 65 or above between 2010 and 2016 at a single institution

  Characteristic                       Value
  ------------------------------------ ---------------------
  Mean age                             80.6±8.5 (65--97)
  Gender                               
   Female                              42 (60)
   Male                                28 (40)
  Ethnicity                            
   European                            62 (88)
   Maori/Pacific Islander              7 (10)
   Asian                               1 (1.4)
  Mean Charlson Comorbidity Index      5.3±2.2 (2--10)
  Mean modified Frailty Index          0.21±0.15 (0--0.55)
  Mechanism of injury                  
   Fall from standing height           52 (74.3)
   High speed MVC                      12 (17.1)
   Low speed MVC                       4 (5.7)
   Pedestrian vs. car                  2 (2.9)
  Abnormal neurology on presentation   8 (11.4)
  Treatment modality                   
   Hard collar                         38 (54.3)
   Soft collar                         10 (14.3)
   Halo-vest                           5 (7.1)
   Minerva brace                       8 (11.4)
   Traction/tongs                      1 (1.4)
   Surgery                             8 (11.4)
  Average length of stay               10.4±12.5 (0--77)
  Readmission within 90 days           20 (28.5)
  Mortality                            
   30-Day                              10 (14.3)
   1-Year                              25 (35.7)

Values are presented as mean±standard deviation (range) or number (%).

MVC, motor vehicle collision.

###### 

Bivariate analysis of 30-day and 1-year mortality rates, 90-day readmission rates and length of stay

  Variable                                              30-Day mortality   1-Year mortality   90-Day readmission   Length of stay                                    
  ----------------------------------------------------- ------------------ ------------------ -------------------- ---------------- ----------- ----------- -------- -------
  Charlson Comorbidity Index                            **0.367**          **0.002**          **0.690**            \< 0.001         0.142       0.241       -0.204   0.090
  mFI^[a)](#tfn1-asj-2018-0300){ref-type="table-fn"}^   **0.313**          **0.008**          **0.583**            **\<0.001**      **0.331**   **0.005**   -0.075   0.537
   Pre-frail                                            -0.140             0.371              0.063                0.689            0.122       0.437       0.128    0.412
   Frail                                                0.203              0.228              **0.538**            **0.001**        0.320       0.053       0.020    0.905
  Haemoglobin (g/L)                                     **-0.373**         **0.001**          -0.319               0.007            -0.070      0.951       -0.170   0.161
  Lymphocyte count                                      0.077              0.524              0.037                0.759            -0.133      0.271       -0.032   0.792
  Albumin (g/L)                                         **-0.286**         **0.016**          **-0.350**           **0.003**        -0.101      0.405       -0.082   0.498
  Creatinine (µmol/L)                                   0.061              0.616              0.233                0.053            0.053       0.661       0.037    0.759

Significant results in bold type.

mFI, modified Frailty Index.

Pre-frail: mFI, 0.09--0.18; frail: mFI ≥0.27.

###### 

Multivariate analysis of 30-day and 1-year mortality using forward stepwise regression modelling

  Variables entered into analysis                        30-Day mortality (final model)   1-Year mortality (final model)                            
  ------------------------------------------------------ -------------------------------- -------------------------------- ------------------------ -------
  Age                                                    \-                               0.181                            1.154 (1.003--1.329)     0.045
  Female gender                                          \-                               0.453                            11.188 (1.307--95.795)   0.028
  Charlson Comorbidity Index                             1.614 (1.145--2.276)             0.006                            2.875 (1.579--5.235)     0.001
  Modified Frailty Index                                 \-                               0.797                            \-                       0.59
  Haemoglobin                                            0.919 (0.866--0.975)             0.005                            \-                       0.061
  Lymphocyte count                                       \-                               0.658                            \-                       0.098
  Albumin                                                \-                               0.318                            0.762 (0.621--0.936)     0.01
  Creatinine                                             0.989 (0.976--1.002)             0.095                            \-                       0.851
  *R*^2[a)](#tfn2-asj-2018-0300){ref-type="table-fn"}^   0.431                            0.762                                                     

OR, odds ratio; CI, confidence interval.

Coefficient of determination.
